The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

Abstract Objectives Severe acute respiratory infection (SARI) caused by the SARS-CoV-2 virus may cause lung failure and the need for mechanical ventilation. Infection with SARS-COV-2 can lead to activation of inflammatory factors, increased reactive oxygen species, and cell damage. In addition to mu...

Full description

Bibliographic Details
Main Authors: Arash Rahimi, Hamid Reza Samimagham, Mehdi Hassani Azad, Dariush Hooshyar, Mohsen Arabi, Mitra KazemiJahromi
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Trials
Subjects:
COVID-19
Randomised controlled trial
Protocol
N-acetylcysteine
Online Access:https://doi.org/10.1186/s13063-021-05242-4

Internet

https://doi.org/10.1186/s13063-021-05242-4

Similar Items